| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8658100 | Chest | 2018 | 29 Pages |
Abstract
This study suggests that there is a dose-response relationship between current BZRA use and the risk of hospitalization for pneumonia. In addition, benzodiazepine hypnotic agents, especially midazolam, present a greater risk of hospitalization for pneumonia. These findings reinforce the importance of a careful analysis of the benefits vs the risks of BZRA use.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Tien-Yu MD, John W. MD, PhD, Wei-Chung MD, Chia-Lin MD, Chung-Yao MD, PhD, Chi-Shin MD, PhD,